The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Polymeric Nanocarriers of Drug Delivery Systems in Cancer Therapy
Open accessAbstract
Conventional chemotherapy is the most common therapeutic method for treating cancer by the application of small toxic molecules thatinteract with DNA and causecell death. Unfortunately, these chemotherapeutic agents are non-selective and can damage both cancer and healthy tissues, producing diverse side effects, andthey can have a short circulation half-life and limited targeting. Many synthetic polymers have found application as nanocarriers of intelligent drug delivery systems (DDSs). Their unique physicochemical properties allow them to carry drugs with high efficiency, specificallytarget cancer tissue and control drug release. In recent years, considerable efforts have been made to design smart nanoplatforms, including amphiphilic block copolymers, polymer-drug conjugates and in particular pH- and redox-stimuli-responsive nanoparticles (NPs). This review is focused on a new generation of polymer-based DDSs with specific chemical functionalities that improve their hydrophilicity, drug loading and cellular interactions.Recentlydesigned multifunctional DDSs used in cancer therapy are highlighted in this review.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
Knop, K., Hoogenboom, R., Fischer, D., & Schubert, U. S. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200902672 · Cited by 3,533 · cited 1×
“A frequently used hydrophilic polymer of DDSs is PEG, which providesdistinctstability to NPs due to the reduction of nonspecific interactions with blood proteins, thus preventing their aggregation [36].”
BackgroundAdvanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
Pérez-Herrero, E., & Fernández-Medarde, A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.018 · Cited by 1,875
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo
Farokhzad, O. C., Cheng, J., Teply, B. A., Sherifi, I., Jon, S., Kantoff, P. W., Richie, J. P., & Langer, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601755103 · Cited by 1,663
Ligand-targeted therapeutics in anticancer therapy
Allen, T. M. (2002) · Nature Reviews Cancer · doi:10.1038/nrc903 · Cited by 1,647
Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: A review
Hossen, S., Hossain, M. K., Basher, M. K., Mia, M. N. H., Rahman, M. T., & Uddin, M. J. (2019) · Journal of Advanced Research · doi:10.1016/j.jare.2018.06.005 · Cited by 998 · cited 2×
“In the last few decades, nanomedicine has assumed an important role in cancer therapy based on diverse tailor-made drug delivery systems (DDSs) [7].”
BackgroundCancer nanomedicine: A review of recent success in drug delivery
Tran, S., DeGiovanni, P., Piel, B., & Rai, P. (2017) · Clinical and Translational Medicine · doi:10.1186/s40169-017-0175-0 · Cited by 879
Progress of drug-loaded polymeric micelles into clinical studies
Cabral, H., & Kataoka, K. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.042 · Cited by 837
Bae, Y., Nishiyama, N., Fukushima, S., Koyama, H., Yasuhiro, M., & Kataoka, K. (2005) · Bioconjugate Chemistry · doi:10.1021/bc0498166 · Cited by 742
Wang, H., Zhao, Y., Wu, Y., Hu, Y.-L., Nan, K., Nie, G., & Chen, H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.07.032 · Cited by 603
HPMA copolymers: Origins, early developments, present, and future☆
Kopeček, J., & Kopečková, P. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.10.004 · Cited by 576
Aptamer-functionalized PEG–PLGA nanoparticles for enhanced anti-glioma drug delivery
Guo, J., Gao, X., Su, L., Xia, H., Gu, G., Pang, Z., Jiang, X., Yao, L., Chen, J., & Chen, H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.07.004 · Cited by 566
Hamaguchi, T., Matsumura, Y., Suzuki, M., Shimizu, K., Goda, R., Nakamura, I., Nakatomi, I., Yokoyama, M., Kataoka, K., & Kakizoe, T. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602479 · Cited by 565
Nanoparticles and targeted drug delivery in cancer therapy
Bahrami, B., Hojjat-Farsangi, M., Mohammadi, H., Anvari, E., Ghalamfarsa, G., Yousefi, M., & Jadidi-Niaragh, F. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.07.015 · Cited by 510
Calzoni, E., Cesaretti, A., Polchi, A., Di Michele, A., Tancini, B., & Emiliani, C. (2019) · Journal of Functional Biomaterials · doi:10.3390/jfb10010004 · Cited by 468
PEG conjugates in clinical development or use as anticancer agents: An overview
Pasut, G., & Veronese, F. M. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.02.010 · Cited by 457
Miura, Y., Takenaka, T., Toh, K., Wu, S., Nishihara, H., Kano, M. R., Ino, Y., Nomoto, T., Matsumoto, Y., Koyama, H., et al. (2013) · ACS Nano · doi:10.1021/nn402662d · Cited by 454
Bae, Y., Jang, W.-D., Nishiyama, N., Fukushima, S., & Kataoka, K. (2005) · Molecular BioSystems · doi:10.1039/b500266d · Cited by 445
Hepatic Drug Targeting: Phase I Evaluation of Polymer-Bound Doxorubicin
Seymour, L. W., Ferry, D. R., Anderson, D., Hesslewood, S., Julyan, P. J., Poyner, R., Doran, J., Young, A., Burtles, S. S., & Kerr, D. J. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1668 · Cited by 435
Plummer, R., Wilson, R. H., Calvert, H., Boddy, A. V., Griffin, M., Sludden, J., Tilby, M. J., Eatock, M., Pearson, D. G., Ottley, C. J., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.6 · Cited by 390
Zhou, S., Deng, X., & Yang, H. (2003) · Biomaterials · doi:10.1016/s0142-9612(03)00207-2 · Cited by 383
Danson, S., Ferry, D., Alakhov, V, Margison, J., Kerr, D., Jowle, D., Brampton, M., Halbert, G., & Ranson, M. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601856 · Cited by 382
Lv, S., Tang, Z., Li, M., Lin, J., Song, W., Liu, H., Huang, Y., Zhang, Y., & Chen, X. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.04.034 · Cited by 345
Seymour (2009) · International Journal of Oncology · doi:10.3892/ijo_00000293 · Cited by 304
Valle, J. W., Armstrong, A., Newman, C., Alakhov, V., Pietrzynski, G., Brewer, J., Campbell, S., Corrie, P., Rowinsky, E. K., & Ranson, M. (2011) · Investigational New Drugs · doi:10.1007/s10637-010-9399-1 · Cited by 303
Polymers and Drug Delivery Systems
Vilar, G., Tulla-Puche, J., & Albericio, F. (2012) · Current Drug Delivery · doi:10.2174/156720112801323053 · Cited by 296
Hamaguchi, T., Kato, K., Yasui, H., Morizane, C., Ikeda, M., Ueno, H., Muro, K., Yamada, Y., Okusaka, T., Shirao, K., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603855 · Cited by 290
Torchilin, V. P. (2008) · Peptide Science · doi:10.1002/bip.20989 · Cited by 283
Meerum Terwogt, J. M., ten Bokkel Huinink, W. W., Schellens, J. H., Schot, M., Mandjes, I. A., Zurlo, M. G., Rocchetti, M., Rosing, H., Koopman, F. J., & Beijnen, J. H. (2001) · Anti-Cancer Drugs · doi:10.1097/00001813-200104000-00003 · Cited by 279
Poly (amino acid) micelle nanocarriers in preclinical and clinical studies
Matsumura, Y. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.11.010 · Cited by 275
Duncan, R., & Vicent, M. J. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.12.005 · Cited by 230
Co-delivery of drugs and plasmid DNA for cancer therapy
Teo, P. Y., Cheng, W., Hedrick, J. L., & Yang, Y. Y. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.10.014 · Cited by 229
Cao, N., Cheng, D., Zou, S., Ai, H., Gao, J., & Shuai, X. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.11.061 · Cited by 229
Wang, Y., Yu, L., Han, L., Sha, X., & Fang, X. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.12.033 · Cited by 226
Venne, A., Li, S., Mandeville, R., Kabanov, A. V., & Alakhov, V. Y. (1996) · PubMed · Cited by 225
Wang, H., Agarwal, P., Zhao, S., Xu, R. X., Yu, J., Lu, X., & He, X. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.08.048 · Cited by 218
Xu, X., Chen, X., Wang, Z., & Jing, X. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.10.015 · Cited by 213
Hu, D., Chen, L., Qu, Y., Peng, J., Chu, B., Shi, K., Hao, Y., Zhong, L., Wang, M., & Qian, Z. (2018) · Theranostics · doi:10.7150/thno.22989 · Cited by 212
Duan, J., Mansour, H. M., Zhang, Y., Deng, X., Chen, Y., Wang, J., Pan, Y., & Zhao, J. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.01.020 · Cited by 194 · cited 1×
“To date, several NP formulations, such asmPEG-PCL micelles [79], poly(alkyl cyanoacrylate) NPs [80] and PLLA NPs [81], have been obtained for the co-delivery of DOX and CUR, although the majority of these NPs release the drug non-specifically, with a slow degradation of the polymeric micelles.”
BackgroundXiong, X.-B., Ma, Z., Lai, R., & Lavasanifar, A. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.09.080 · Cited by 193
Shi, C., Guo, X., Qu, Q., Tang, Z., Wang, Y., & Zhou, S. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.06.036 · Cited by 189
Julyan, P. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00124-2 · Cited by 180
Navarro, G., Sawant, R. R., Biswas, S., Essex, S., Tros de Ilarduya, C., & Torchilin, V. P. (2012) · Nanomedicine · doi:10.2217/nnm.11.93 · Cited by 170
Antibody-modified liposomes for cancer chemotherapy
Torchilin, V. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.9.1003 · Cited by 168
Sapra, P., Zhao, H., Mehlig, M., Malaby, J., Kraft, P., Longley, C., Greenberger, L. M., & Horak, I. D. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4456 · Cited by 168
ProLindac™ (AP5346): A review of the development of an HPMA DACH platinum Polymer Therapeutic
Nowotnik, D. P., & Cvitkovic, E. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.06.004 · Cited by 167
Dai, X., & Tan, C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.09.010 · Cited by 155
Polymer-based drug delivery systems for cancer treatment
Guo, X., Wang, L., Xiao, W., & Zhou, S. (2016) · Journal of Polymer Science Part A Polymer Chemistry · doi:10.1002/pola.28252 · Cited by 148
Jin, M., Jin, G., Kang, L., Chen, L., Gao, Z., & Huang, W. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s161426 · Cited by 146
Tang, S., Yin, Q., Su, J., Sun, H., Meng, Q., Chen, Y., Chen, L., Huang, Y., Gu, W., Xu, M., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.01.049 · Cited by 145
Wei, W., Lv, P., Chen, X.-M., Yue, Z., Fu, Q., Liu, S., Yue, H., & Ma, G. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.02.030 · Cited by 143
Chen, Y., Zhang, W., Huang, Y., Gao, F., Sha, X., & Fang, X. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.04.048 · Cited by 140
Singer, J. W., Bhatt, R., Tulinsky, J., Buhler, K. R., Heasley, E., Klein, P., & de Vries, P. W. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00323-6 · Cited by 139
In Vivo Distribution of Polymeric Nanoparticles at the Whole-Body, Tumor, and Cellular Levels
Lee, H., Hoang, B., Fonge, H., Reilly, R. M., & Allen, C. J. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0068-z · Cited by 138
Micelle-like Nanoparticles as Carriers for DNA and siRNA
Navarro, G., Pan, J., & Torchilin, V. P. (2015) · Molecular Pharmaceutics · doi:10.1021/mp5007213 · Cited by 130
Campone, M., Rademaker-Lakhai, J. M., Bennouna, J., Howell, S. B., Nowotnik, D. P., Beijnen, J. H., & Schellens, J. H. M. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0397-0 · Cited by 125
Kèlland, L. R. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.7.1009 · Cited by 124
Polymeric Micellar Delivery Systems in Oncology
Matsumura, Y. (2008) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyn116 · Cited by 124
Ma, Y., Fan, X., & Li, L. (2015) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2015.10.050 · Cited by 114
Targeting Integrins in Cancer Nanomedicine: Applications in Cancer Diagnosis and Therapy
Wu, P., Opadele, A. E., Onodera, Y., & Nam, J. (2019) · Cancers · doi:10.3390/cancers11111783 · Cited by 112
Pan, J., Rostamizadeh, K., Filipczak, N., & Torchilin, V. P. (2019) · Molecules · doi:10.3390/molecules24061035 · Cited by 110
Duong, H. H. P., & Yung, L. L. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.06.017 · Cited by 108
Pan, J., Mendes, L. P., Yao, M., Filipczak, N., Garai, S., Thakur, G. A., Sarısözen, C., & Torchilin, V. P. (2019) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2019.01.006 · Cited by 106
Curcumin a potent cancer preventive agent: Mechanisms of cancer cell killing
Tuorkey, M. J. (2014) · Interventional Medicine and Applied Science · doi:10.1556/imas.6.2014.4.1 · Cited by 101
Antitumoral activity of camptothecin-loaded nanoparticles in 9L rat glioma model
Çırpanlı, Y., Allard-Vannier, É., Passirani, C., Bilensoy, E., Lemaire, L. P., Çalış, S., & Benoît, J. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.10.015 · Cited by 99
Hong, G., Yuan, R., Liang, B., Shen, J., Yang, X., & Shuai, X. (2008) · Biomedical Microdevices · doi:10.1007/s10544-008-9180-9 · Cited by 98
Cheng, W., & Allen, T. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425240903579963 · Cited by 98
Gao, X., Luo, Wang, Li, M., Zhang, Qian, Q., Li, M., Shi, H., Fan, M., & Liu (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s45250 · Cited by 96
Surface modification of Mitoxantrone-loaded PLGA nanospheres with chitosan
Chen, H., Yang, W., Chen, H., Liu, L., Gao, F., Xin-du, Y., Jiang, Q., Zhang, Q., & Wang, Y. (2009) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2009.05.020 · Cited by 95
Wang, L., Hao, Y., Li, H., Zhao, Y., Meng, D., Li, D., Shi, J., Zhang, H., Zhang, Z., & Zhang, Y. (2015) · Journal of drug targeting · doi:10.3109/1061186x.2015.1025077 · Cited by 90
Hu, J., Fu, S., Peng, Q., Han, Y., Xie, J., Zan, N., Chen, Y., & Fan, J. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.11.047 · Cited by 90
Vega, J., Ke, S., Fan, Z., Wallace, S., Charsangavej, C., & Li, C. (2003) · Pharmaceutical Research · doi:10.1023/a:1023454107190 · Cited by 89
Shafiei‐Irannejad, V., Samadi, N., Salehi, R., Yousefi, B., Rahimi, M., Akbarzadeh, A., & Zarghami, N. (2018) · Pharmaceutical Research · doi:10.1007/s11095-018-2404-7 · Cited by 89
Cheng, Q., Du, L., Meng, L., Han, S., Wei, T., Wang, X., Wu, Y., Song, X., Zhou, J., Zheng, S., et al. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b11789 · Cited by 85 · cited 2×
“Cationic charged polymers, such as poly(ethyleneimine) (PEI) and poly[2-(N,N-dimethylaminoethyl) methacrylate] (PDMAEMA) [29,30] are suitable for complex binding siRNA by electrostatic interaction, preventing the degradation of siRNA and enhancing its delivery across the cell membrane.”
BackgroundAlinejad, V., Somi, M. H., Baradaran, B., Akbarzadeh, P., Atyabi, F., Kazerooni, H., Kafil, H. S., Maleki, L. A., Mansouri, H. S., & Yousefi, M. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.06.037 · Cited by 85
Clinical developments of antitumor polymer therapeutics
Parveen, S., Arjmand, F., & Tabassum, S. (2019) · RSC Advances · doi:10.1039/c9ra04358f · Cited by 84
Pastorino, F., Loi, M., Sapra, P., Becherini, P., Cilli, M., Emionite, L., Ribatti, D., Greenberger, L. M., Horak, I. D., & Ponzoni, M. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1354 · Cited by 79
Yuan, J., Zhuge, D., Tong, M., Lin, M., Xu, X.-F., Tang, X., Zhao, Y., & Xu, H. (2018) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2017.1423495 · Cited by 78
Wang, X., Liow, S. S., Wu, Q., Li, C., Owh, C., Li, Z., Loh, X. J., & Wu, Y. (2017) · Macromolecular Bioscience · doi:10.1002/mabi.201700186 · Cited by 73
Hopewell, J. W., Duncan, R., Wilding, D., & Chakrabarti, K. (2001) · Human & Experimental Toxicology · doi:10.1191/096032701682693017 · Cited by 72
Oba, M., Vachutinsky, Y., Miyata, K., Kano, M. R., Ikeda, S., Nishiyama, N., Itaka, K., Miyazono, K., Koyama, H., & Kataoka, K. (2010) · Molecular Pharmaceutics · doi:10.1021/mp9002317 · Cited by 70
Huang, H., Kuo, W., Chou, M., & Huang, Y. (2011) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.33055 · Cited by 61
Wen, X., Wu, Q. P., Ke, S., Ellis, L., Charnsangavej, C., Delpassand, A. S. E. S., Wallace, S., & Li, C. (2001) · PubMed · Cited by 55
Crozier, J. A., Advani, P. P., LaPlant, B. R., Hobday, T. J., Jaslowski, A. J., Moreno‐Aspitia, A., & Perez, E. A. (2015) · Clinical Breast Cancer · doi:10.1016/j.clbc.2015.08.002 · Cited by 53
Guo, Q., Li, X., Yang, Y., Wei, J., Zhao, Q., Luo, F., & Qian, Z. (2013) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2014.1785 · Cited by 53
Zhang, Z., Qu, Q., Li, J., & Zhou, S. (2013) · Macromolecular Bioscience · doi:10.1002/mabi.201300037 · Cited by 48
Perspective highlights on biodegradable polymeric nanosystems for targeted therapy of solid tumors
Fathi, M., & Barar, J. (2017) · Bioimpacts · doi:10.15171/bi.2017.07 · Cited by 46
Wilson, R. H., Plummer, R., Adam, J., Eatock, M. M., Boddy, A. V., Griffin, M., Miller, C. R., Matsumura, Y., Shimizu, T., & Calvert, H. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.2573 · Cited by 34
Das, L., & Vinayak, M. (2014) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2014.889824 · Cited by 31
Li, N., Huang, C., Luan, Y., Song, A., Song, Y., & Garg, S. (2016) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2016.03.039 · Cited by 27
The impact of multiple drug resistance (MDR) proteins on chemotherapy and drug discovery
Skatrud, P. L. (2002) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8183-8_3 · Cited by 22
Insights into the Chemical Biology of Childhood Embryonal Solid Tumors by NMR-Based Metabolomics
Quintero, M., Maschietto, M. C., Krepischi, A. C. V., Avramović, N., & Tasić, L. (2019) · Biomolecules · doi:10.3390/biom9120843 · Cited by 22
Self-citation
Cited by
Polymeric Nanoparticles: Production, Characterization, Toxicology and Ecotoxicology
Zielińska, A., Carreiró, F., Oliveira, A. M., Neves, A., Pires, B., Venkatesh, D. N., Durazzo, A., Lucarini, M., Eder, P., Silva, A. M., et al. (2020) · Molecules · doi:10.3390/molecules25163731 · Cited by 1,560
Chehelgerdi, M., Chehelgerdi, M., Allela, O. Q. B., Pecho, R. D. C., Jayasankar, N., Rao, D. P., Thamaraikani, T., Vasanthan, M., Viktor, P., Lakshmaiya, N., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01865-0 · Cited by 1,062
Scale-up polymeric-based nanoparticles drug delivery systems: Development and challenges
Herdiana, Y., Wathoni, N., Shamsuddin, S., & Muchtaridi, M. (2022) · OpenNano · doi:10.1016/j.onano.2022.100048 · Cited by 329
Metadata
- Authors
- Avramović, N., Mandić, B., Savić-Radojević, A., & Simić, T.
- Venue
- Pharmaceutics
- Publisher
- MDPI AG
- Published
- 2020-03-25
- Volume
- 12
- Issue
- 4
- Pages
- 298
- ISSN
- 1999-4923 (ISSN-L)
- OpenAlex
- W3013627576
- Cited by
- 296
- References
- 91
- FWCI
- 8.16
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.